Allon Therapeutics Inc. to Present at Fasken Martineau Forum June 2, 2006 Angiotech Pharmaceuticals to acquire Quill Medical Inc. May 25, 2006 Angiotech provides 2006 and 2007 financial update at its annual analyst day May 25, 2006 Angiotech Pharmaceuticals announces TAXUS(R) Liberté(TM) stent system receives European approval for three complex coronary procedures May 16, 2006 Angiotech Pharmaceuticals announces TAXUS VI results support positive safety and efficacy profile May 16, 2006 Angiotech Pharmaceuticals announces TAXUS ATLAS trial supports superior deliverability and proven outcomes of TAXUS(R) Liberté(TM) stent system May 16, 2006 Angiotech Pharmaceuticals, Inc. announces results for the first quarter of 2006 May 9, 2006  Angiotech Pharmaceuticals and Genzyme Corporation Form Collaboration to Develop Innovative Surgical Oncology Treatments May 9, 2006 Boston Scientific and Angiotech Win Patent Infringement Case Against Sahajanand in the Netherlands May 3, 2006 AnorMED announces departure of Vice President Communications June 2, 2006 AnorMED President and CEO Michael Abrams steps down May 24, 2006 Aspreva Pharmaceuticals added to the NASDAQ Biotechnology Index(R) May 23, 2006  Aspreva Pharmaceuticals to Present at the Banc of America Health Care Conference in Las Vegas May 9, 2006 CANTEST Chairman inducted into Business Hall of Fame May 19, 2006 Cardiome Announces Refusal to File Decision by the FDA May 31, 2006 Cardiome to Hold Conference Call May 30, 2006 Cardiome to Present at Investor Conference May 30, 2006 Cardiome Pharma Corp. Announces Sun Run Corporate Challenge Results May 17, 2006 Cardiome to Present at Investor Conference May 11, 2006 Cardiome Reports Additional Phase 1 Trial: Data for Oral RSD1235 May 5, 2006 CB Richard Ellis: Biotech Sublease Space Available June 5, 2006 Chemokine Therapeutics Corp. Closes Transaction To Re-Acquire Licensing Rights To CTCE-0214 From Pharmaceutical Product Development, Inc. May 25, 2006 Chemokine Therapeutics to Present at Rodman & Renshaw's Third Annual Global Healthcare Conference May 9, 2006 CIHR/MSFHR Bioinformatics Industrial Research Rotation Program: Call for Company Participants June 2, 2006 Clera Announces Senior Management Appointments May 24, 2006 Leasing Opportunities Available with Discovery Parks May 17, 2006 Forbes Medi-Tech Announces Launch of First Cholesterol-Lowering Cheddar Cheese with Reducol™ at UK Wal-Mart /ASDA May 12, 2006 Forbes Medi-Tech announces Financial Results for the Q1 ended March 31, 2006 ~Product Launches and Strong Financial Position Highlight First Quarter~ May 16, 2006 GenoLogics and Bioinformatics Solutions Collaborate to Integrate Their Proteomics Data Management and Data Visualization Software May 23, 2006 GenoLogics Partners with GeneBio to Enhance Proteomics Lab and Data Management Capabilities for Life Science Researchers May 23, 2006 Inflazyme to Present at Pacific Growth Equities' Life Sciences Growth Conference June 1, 2006 Inflazyme Pharmaceuticals Ltd. Announces Financial Results for the Quarter and Year Ended March 31, 2006 May 23, 2006 Inflazyme Announces Upcoming Presentation on IPL512,602 at the 2006 American Thoracic Society (ATS) International Conference May 11, 2006 Inflazyme Announces Start of Phase IIb Trial with IPL512,602 for Asthma May 9, 2006 Inex Pharmaceuticals Closes Hana Biosciences Licensing Agreement May 8, 2006 Inex Pharmaceuticals Announces Court of Appeal Win May 19, 2006 INEX Releases First Quarter 2006 Operating Results May 3, 2006 Med Biogene Inc. reports financial results for first quarter 2006 May 30, 2006 Med Biogene Inc. appoints Erinn B. Broshko as its new Chief Executive Officer and a director May 19, 2006 Med BioGene Inc. Completes Acquisition of Dragon-Tex (Group) Limited and $2 Million Financing May 5, 2006 MIGENIX releases CEO message No. 18a May 25, 2006 MIGENIX Receives Approval for MX-3253 Phase II Combination Viral Kinetics Study in HCV Treatment-Naive Patients May 16, 2006 MIGENIX Raises $8.8 Million May 4, 2006 Neuromed Pharmaceuticals Named Life Sciences Company of the Year May 4, 2006 OncoGenex Announces Encouraging Data from a Phase I Study of Patients with Non-Small Cell Lung Cancer May 3, 2006 Early Warning Report - CEO of Ondine Biopharma increases ownership in company June 2, 2006 Ondine Biopharma Announces Collaborative Development Program for Photodynamic Anti-Infectives May 16, 2006 Perceptronix Receives CE Mark For its CE ClearSign™ Sputum Test For Early Lung Cancer May 26, 2006 Protox Releases Q1, 2006 Financial Statements May 29, 2006   QLT Strengthens Corporate Development & Legal Functions with the Appointment of Peter J. O'Callaghan as SVP, Corporate Development and General Counsel May 25, 2006 QLT delays initiation of Phase IIa Atrigel/octreotide program May 18, 2006   QLT Announces TSX Approval of Second Year of Two-Year Share Repurchase Program May 8, 2006 Stressgen changes name to Nventa Biopharmaceuticals Corporation June 1, 2006 Stressgen Biotechnologies announces first quarter 2006 financial results May 11, 2006 Welichem announces grant of incentive stock options May 12, 2006 Urigen and Kalium Sign Clinical Stage Licensing Agreement May 22, 2006

send this to a friend unsubscrive © BC BIOTECH. All rights reserved.

Suite 900 - 1188 West Georgia St. Vancouver, BC V6E 4A2